Is there a rationale for bladder cancer screening?
Screening should decrease disease-related mortality by detecting cancer before symptoms prompt evaluation. Several characteristics of bladder cancer make screening an attractive option. Nevertheless, premature adoption of a screening program has considerable negative consequences. This article reviews the current literature regarding screening for bladder cancer and emphasizes the need for prospective, clinical trials before considering practice modification.